NST logo

Nestmedic S.A. Stock Price

WSE:NST Community·zł29.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

NST Share Price Performance

zł0.69
0.16 (30.94%)
zł0.69
0.16 (30.94%)
Price zł0.69

NST Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with worrying balance sheet.

6 Risks
0 Rewards

Nestmedic S.A. Key Details

zł1.1m

Revenue

zł317.2k

Cost of Revenue

zł736.5k

Gross Profit

zł5.4m

Other Expenses

-zł4.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
May 13, 2026
-0.11
69.90%
-447.08%
60.6%
View Full Analysis

About NST

Founded
2017
Employees
3
CEO
Jacek Gnich
WebsiteView website
www.nestmedic.com

Nestmedic S.A., together with its subsidiaries, manufactures, distributes, and sells telemedicine solutions under the Pregnabit brand. It offers Pregnabit and Pregnabit Pro medical devices operating in a telediagnostic model that support the work of doctors and midwives in measuring fetal heart rate and uterine contraction activity, as well as signaling fetal movements for monitoring fetal and maternal well-being in the final weeks of pregnancy. The company also provides Pregnabit Cloud, a software as a service system designed to work with telemedical cardiotocography examination devices implementing the required communication protocol to send measurement data during an examination; and PregnaView, a component of the Pregnabit system that functions as a separate medical device. It sells its products through a distribution network and resellers worldwide. Nestmedic S.A. was incorporated in 2017 and is headquartered in Warsaw, Poland.

Recent NST News & Updates

Recent updates

No updates